Pseudomonas aeruginosa Exolysin promotes bacterial growth in lungs, alveolar damage and bacterial dissemination.
Stéphanie BouillotPatrick MunroBenoît GalletEmeline ReboudFrançois CretinGuillaume GolovkineGuy SchoehnIna AttréeEmmanuel LemichezPhilippe HuberPublished in: Scientific reports (2017)
Exolysin (ExlA) is a recently-identified pore-forming toxin secreted by a subset of Pseudomonas aeruginosa strains identified worldwide and devoid of Type III secretion system (T3SS), a major virulence factor. Here, we characterized at the ultrastructural level the lesions caused by an ExlA-secreting strain, CLJ1, in mouse infected lungs. CLJ1 induced necrotic lesions in pneumocytes and endothelial cells, resulting in alveolo-vascular barrier breakdown. Ectopic expression of ExlA in an exlA-negative strain induced similar tissue injuries. In addition, ExlA conferred on bacteria the capacity to proliferate in lungs and to disseminate in secondary organs, similar to bacteria possessing a functional T3SS. CLJ1 did not promote a strong neutrophil infiltration in the alveoli, owing to the weak pro-inflammatory cytokine reaction engendered by the strain. However, CLJ1 was rapidly eliminated from the blood in a bacteremia model, suggesting that it can be promptly phagocytosed by immune cells. Together, our study ascribes to ExlA-secreting bacteria the capacity to proliferate in the lung and to damage pulmonary tissues, thereby promoting metastatic infections, in absence of substantial immune response exacerbation.
Keyphrases
- pseudomonas aeruginosa
- high glucose
- escherichia coli
- endothelial cells
- cystic fibrosis
- immune response
- biofilm formation
- type iii
- diabetic rats
- oxidative stress
- acinetobacter baumannii
- chronic obstructive pulmonary disease
- squamous cell carcinoma
- small cell lung cancer
- drug induced
- gene expression
- pulmonary hypertension
- staphylococcus aureus
- binding protein
- intensive care unit
- long non coding rna
- drug resistant